col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


108 Results       Page 1

 [1] 
Springer-Verlag: Clinical Rheumatology
  original article Date Title Authors   All Authors
1 [GO] 2022―May―20 Modification of immunomodulatory medications by rheumatology patients during the peak of the COVID-19 pandemic in New York City Medha Barbhaiya, Marianna B. Frey, Jonah Levine, Gregory Vitone, Lindsay Lally, Michael D. Lockshin, et al. (+3)
2 [GO] 2022―May―14 Patients with idiopathic inflammatory myopathies suffer from worse self-reported PROMIS physical function after COVID-19 infection: an interview-based study from the MyoCite cohort Rajat Kharbanda, Keya Ganatra, Maryam Abbasi, Vikas Agarwal, Latika Gupta
3 [GO] 2022―May―05 Factors affecting patient satisfaction with outpatient rheumatology phone visits during the COVID-19 pandemic Hart A. Goldhar, Ummugulsum Gazel, Catherine Ivory, Nancy Maltez, Susan Humphrey-Murto, Nataliya Milman, Sibel Zehra Aydin
4 [GO] 2022―May―02 Different systemic rheumatic diseases as risk factors for COVID-19-related mortality George E. Fragoulis, Vasiliki-Kalliopi Bournia, Petros P. Sfikakis
5 [GO] 2022―Apr―30 Clinical course and seroprevalence of COVID-19 in children with rheumatic diseases-cross-sectional study from a reference centre in Spain Clara Udaondo, Claudia Millán-Longo, Celia Permuy, Laura Valladares, Iker Falces-Romero, Celia Muñoz-Gómez, et al. (+5)
6 [GO] 2022―Apr―02 COVID-19 among patients with giant cell arteritis: a single-centre observational study from Slovenia Jelka Kramarič, Rok Ješe, Matija Tomšič, Žiga Rotar, Alojzija Hočevar
7 [GO] 2022―Mar―30 Prevalence and risk of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis Feier Wang, Yubo Ma, Shanshan Xu, Huanhuan Liu, Yuting Chen, Hui Yang, et al. (+7)
8 [GO] 2022―Mar―19 Inactivated SARS-CoV-2 vaccine in primary Sjögren’s syndrome: humoral response, safety, and effects on disease activity Sandra Gofinet Pasoto, Ari Stiel Radu Halpern, Lissiane Karine Noronha Guedes, Ana Cristina Medeiros Ribeiro, Emily Neves Figueiredo Yuki, Carla Gonçalves Schahin Saad, et al. (+13)
9 [GO] 2022―Mar―16 Systemic lupus erythematous after Pfizer COVID-19 vaccine: a case report Chantal Lemoine, Cristina Padilla, Noah Krampe, Sean Doerfler, Adam Morgenlander, Brent Thiel, Rohit Aggarwal
10 [GO] 2022―Mar―05 Reactive arthritis before and after the onset of the COVID-19 pandemic Dana Bekaryssova, Marlen Yessirkepov, Olena Zimba, Armen Yuri Gasparyan, Sakir Ahmed
11 [GO] 2022―Feb―19 Flare of adult-onset Still’s disease following mRNA COVID-19 vaccination: a case report and review of literature Ji-Won Kim, Ju-Yang Jung, Chang-Hee Suh, Hyoun-Ah Kim
12 [GO] 2022―Feb―17 Systemic lupus erythematosus with acute pancreatitis and vasculitic rash following COVID-19 vaccine: a case report and literature review Alrashdi Mousa N, Alanazi Majed Saleh, Almoaqly Khalid, Abdulrahman Khaled Alshaya, Sultan Mahja Marzouq Alanazi
13 [GO] 2022―Feb―16 Clinical outcomes of COVID-19 patients with rheumatic diseases: a retrospective cohort study and synthesis analysis in Wuhan, China Geyao Qi, Hao Wang, Yufeng Guo, Chi Peng, Chenxu Zhang, Ting Chen, et al. (+2)
14 [GO] 2022―Feb―03 New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword? Ana M. Anzola, Laura Trives, Julia Martínez-Barrio, Blanca Pinilla, José María Álvaro-Gracia, Juan Molina-Collada
15 [GO] 2022―Jan―29 Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases Francesco Ursini, Piero Ruscitti, Vincenzo Raimondo, Rossella De Angelis, Fabio Cacciapaglia, Erika Pigatto, et al. (+28)
16 [GO] 2022―Jan―27 COVID-19 vaccination outcomes among patients with dermatomyositis: a multicentered analysis Haig Pakhchanian, Ahmad Saud, Rahul Raiker, Sinan Kardes, Rohit Aggarwal, Latika Gupta
17 [GO] 2022―Jan―19 Asymptomatic SARS-CoV-2 seropositivity: patients with childhood-onset rheumatic diseases versus healthy children Fatih Haslak, Dogukan Ozbey, Mehmet Yildiz, Amra Adrovic, Sezgin Sahin, Oya Koker, et al. (+7)
18 [GO] 2022―Jan―18 New-onset Adult-onset Still’s disease-like syndrome after ChAdOx1 nCoV-19 vaccination-a case series with review of literature Shivraj Padiyar, Navaneeth Kamath, John Mathew, A. S. Chandu, Divya Deodhar, B. A. Shastry, et al. (+2)
19 [GO] 2021―Nov―29 Coronavirus disease 2019 in patients with Behcet’s disease: a report of 59 cases in Iran Farhad Shahram, Kamal Esalatmanesh, Alireza Khabbazi, Zahra Rezaieyazdi, Zahra Mirfeizi, Alireza Sadeghi, et al. (+4)
20 [GO] 2021―Nov―27 Axial spondyloarthritis may protect against poor outcomes in COVID-19: propensity score matched analysis of 9766 patients from a nationwide multi-centric research network Rahul Raiker, Haig Pakhchanian, Chengappa Kavadichanda, Latika Gupta, Sinan Kardeş, Sakir Ahmed
21 [GO] 2021―Nov―25 Gout during the SARS-CoV-2 pandemic: increased flares, urate levels and functional improvement Juan Salvador García-Maturano, David Eduardo Torres-Ordaz, Miguel Mosqueda-Gutiérrez, Citlallyc Gómez-Ruiz, Aarón Vázquez-Mellado, Alicia Tafoya-Amado, et al. (+3)
22 [GO] 2021―Nov―16 Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus Ernesto Zavala-Flores, Jannin Salcedo-Matienzo, Ana Quiroz-Alva, Alfredo Berrocal-Kasay
23 [GO] 2021―Nov―05 The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life Khadija El Aoufy, Maria Ramona Melis, Silvia Bellando Randone, Jelena Blagojevic, Francesca Bartoli, Ginevra Fiori, et al. (+9)
24 [GO] 2021―Oct―30 Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus Medha Barbhaiya, Jonah M. Levine, Caroline H. Siegel, Vivian P. Bykerk, Deanna Jannat-Khah, Lisa A. Mandl
25 [GO] 2021―Oct―29 Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months Fatih Karaarslan, Fulya Demircioğlu Güneri, Sinan Kardeş
26 [GO] 2021―Oct―04 Emergence of de novo cutaneous vasculitis post coronavirus disease (COVID-19) vaccination Ian Liang, Sanjay Swaminathan, Adrian Y. S. Lee
27 [GO] 2021―Sep―28 Perceptions and behaviours related to COVID-19 in patients with rheumatoid arthritis: a cross-sectional study Takahiro Itaya, Mie Torii, Motomu Hashimoto, Kazuaki Jindai, Wataru Yamamoto, Kyosuke Tanigawa, et al. (+10)
28 [GO] 2021―Sep―25 COVID-19 among patients with Behçet syndrome in the United States Haig Pakhchanian, Rahul Raiker, Sinan Kardeş
29 [GO] 2021―Sep―25 The presence of rheumatological conditions is not a risk factor of long-term post-COVID symptoms after SARS-CoV-2 infection: a multicenter study César Fernández-de-las-Peñas, José D. Martín-Guerrero, Esperanza Navarro-Pardo, Stella Fuensalida-Novo, María Palacios-Ceña, María Velasco-Arribas, Oscar J. Pellicer-Valero
30 [GO] 2021―Sep―12 Impact of COVID-19 on hospitalization of patients with systemic lupus erythematosus (SLE) Wendy Wan Hui Lee, Yaw Kiet Cheong, Cheng Lay Teh, Sharifah Aishah Wan, Seow Lin Chuah, Benjamin Sachdev Manjit Singh
31 [GO] 2021―Aug―24 Janus kinase inhibitors and major COVID-19 outcomes: time to forget the two faces of Janus! A meta-analysis of randomized controlled trials Dimitrios Patoulias, Michael Doumas, Christodoulos Papadopoulos, Asterios Karagiannis
32 [GO] 2021―Jul―03 Antimalarial drugs-are they beneficial in rheumatic and viral diseases?-considerations in COVID-19 pandemic Bogna Grygiel-Górniak
33 [GO] 2021―Jul―03 Depression and anxiety might not be increased during COVID-19 pandemic in patient with axial spondyloarthritis E. Erpek, D. Solmaz, D. Bayraktar, S. Akar
34 [GO] 2021―Jul―02 A bibliometric analysis of rheumatology and COVID-19 researches Ozge Pasin, Tugce Pasin
35 [GO] 2021―Jun―29 Factors associated with COVID-19 and its outcome in patients with rheumatoid arthritis Aida Malek Mahdavi, Mojtaba Varshochi, Mehrzad Hajialilo, Saeed Dastgiri, Raha Khabbazi, Alireza Khabbazi
36 [GO] 2021―Jun―29 Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up Rocío-V. Gamboa-Cárdenas, Silvia Barzola-Cerrón, Denisse Toledo-Neira, Cristina Reátegui-Sokolova, Víctor Pimentel-Quiroz, Francisco Zevallos-Miranda, et al. (+2)
37 [GO] 2021―Jun―25 Isolated “puffy hands” following COVID-19: clue to a long-term capillary leakage syndrome? Jacopo Ciaffi, Riccardo Meliconi, Piero Ruscitti, Annamaria Iagnocco, Clodoveo Ferri, Roberto Giacomelli, Francesco Ursini
38 [GO] 2021―Jun―22 Antibody responses after documented COVID-19 disease in patients with autoimmune rheumatic disease Padmanabha Shenoy, Sakir Ahmed, K. C. Shanoj, Veena Shenoy, Deepak Damodaran, Aparna R. Menon, et al. (+3)
39 [GO] 2021―Jun―05 Clinical features and outcomes of 76 patients with COVID-19-related multi-system inflammatory syndrome in children Fatih Haslak, Kenan Barut, Cansu Durak, Ayten Aliyeva, Mehmet Yildiz, Vafa Guliyeva, et al. (+15)
40 [GO] 2021―May―29 Risk of COVID-19 infection in patients with rheumatic disease taking disease-modifying anti-rheumatic drugs Behnaz Yousefghahari, Sanaz Navari, Mahmoud Sadeghi, Shima Soleimaniamiri, Mohammadjafar Soleimaniamiri, Behzad Heidari, et al. (+4)
41 [GO] 2021―May―28 Rheumatology and psychiatry: allies in times of COVID-19 Claudia Elera-Fitzcarrald, Jeff Huarcaya-Victoria, Graciela S. Alarcón, Manuel F. Ugarte-Gil
42 [GO] 2021―Apr―29 Coronavirus disease 2019 (COVID-19) vaccination in systemic lupus erythematosus and anti-neutrophil cytoplasmic antibody-associated vasculitis Jackie Sim, Cynthia Ciwei Lim
43 [GO] 2021―Apr―07 Are antiphospholipid antibodies just a common epiphenomenon or are they causative of immune-mediated coagulopathy in COVID-19? Diana Castillo-Martínez, Zaira Torres, Luis M. Amezcua-Guerra, Carlos Pineda
44 [GO] 2021―Mar―22 A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review Mehmet Soy, Gökhan Keser, Pamir Atagunduz, Melek Yalçin Mutlu, Alper Gunduz, Gizem Koybaşi, Cemal Bes
45 [GO] 2021―Mar―19 Correction to: Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean Yasemin Ozsurekci, Sibel Gürlevik, Selman Kesici, Ummusen Kaya Akca, Pembe Derin Oygar, Kubra Aykac, et al. (+13)
46 [GO] 2021―Mar―17 COVID-19 and the clinical course of rheumatic manifestations Sakir Ahmed, Olena Zimba, Armen Yuri Gasparyan
47 [GO] 2021―Mar―06 The impact of SARS-CoV-2 coronavirus infection in patients with systemic lupus erythematosus from a single center in Catalonia Gerard Espinosa, Sergio Prieto-González, Mireia Llevadot, Javier Marco-Hernández, Antonio Martínez-Artuña, Albert Pérez-Isidro, et al. (+2)
48 [GO] 2021―Feb―12 Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean Yasemin Ozsurekci, Sibel Gürlevik, Selman Kesici, Ummusen Kaya Akca, Pembe Derin Oygar, Kubra Aykac, et al. (+12)
49 [GO] 2021―Jan―25 Impact of COVID-19 on rheumatology practice in the UK-a pan-regional rheumatology survey Arvind Nune, Karthikeyan P. Iyengar, Ashar Ahmed, Syed Bilgrami, Hem Raj Sapkota
50 [GO] 2021―Jan―19 Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies Antonio Cristiano, Valentina Fortunati, Fabio Cherubini, Sergio Bernardini, Marzia Nuccetelli
51 [GO] 2021―Jan―15 Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset decades of clinical practice? Lucie Pothen, Halil Yildiz, Mathilde Mbouck Samnick, Jean Cyr Yombi
52 [GO] 2021―Jan―11 Superior mesenteric artery syndrome in a patient with rheumatoid arthritis and rheumatoid cachexia during the COVID-19 pandemic Dionicio Ángel Galarza-Delgado, Diana Elsa Flores-Alvarado, Jesús Eduardo Compeán-Villegas
53 [GO] 2021―Jan―11 Tracking awareness for Kawasaki disease in children related to the COVID-19 pandemic Steffen Springer, Artur Strzelecki, Michael Zieger
54 [GO] 2021―Jan―11 COVID-19 vaccination in immunocompromised patients Bhavin Sonani, Fawad Aslam, Amandeep Goyal, Janki Patel, Pankaj Bansal
55 [GO] 2021―Jan―09 Clinical course and outcomes of COVID-19 in rheumatic disease patients: a case cohort study with a diverse population Timothy Arleo, David Tong, Julie Shabto, Ghazala O’Keefe, Arezou Khosroshahi
56 [GO] 2021―Jan―07 COVID-19, rheumatic diseases and immune dysregulation-a perspective Shahna Tariq, Charmaine Van Eeden, Jan Willem Cohen Tervaert, Mohammed S. Osman
57 [GO] 2021―Jan―03 Haemophagocytic syndrome and COVID-19 Soledad Retamozo, Pilar Brito-Zerón, Antoni Sisó-Almirall, Alejandra Flores-Chávez, María-José Soto-Cárdenas, Manuel Ramos-Casals
58 [GO] 2020―Nov―24 Characteristics and evolution of 38 patients with rheumatic diseases and COVID-19 under DMARD therapy Dionicio Ángel Galarza-Delgado, Griselda Serna-Peña, Jesús Eduardo Compeán-Villegas, Jesus Alberto Cardenas-de la Garza, Rita Angélica Pineda-Sic, Iris Jazmín Colunga-Pedraza, et al. (+4)
59 [GO] 2020―Nov―20 COVID-19 in rheumatoid arthritis cases: an Iranian referral center experience Soraya Shadmanfar, Nematollah Jonaidi-Jafari, Ramezan Jafari, Zeynab Rastgar-Moqaddam, Amin Saburi
60 [GO] 2020―Nov―14 COVID-19 and systemic sclerosis: analysis of lifestyle changes during the SARS-CoV-2 pandemic in an Italian single-center cohort Greta Pellegrino, Davide Mohammad Reza Beigi, Carlotta Angelelli, Katia Stefanantoni, Marius Cadar, Silvia Mancuso, et al. (+2)
61 [GO] 2020―Nov―11 Incidence of COVID-19 in patients with rheumatic disease: is prior health education more important than shielding advice during the pandemic? Sarah Kipps, Anindita Paul, Sreekanth Vasireddy
62 [GO] 2020―Oct―31 Population-level interest in anti-rheumatic drugs in the COVID-19 era: insights from Google Trends Sinan Kardeş, Ali Suat Kuzu, Haig Pakhchanian, Rahul Raiker, Mine Karagülle
63 [GO] 2020―Oct―19 Diversifying online rheumatology education options in the era of COVID-19 Sakir Ahmed, Olena Zimba, Armen Yuri Gasparyan
64 [GO] 2020―Oct―16 Challenges, collaboration, and innovation in rheumatology education during the COVID-19 pandemic: leveraging new ways to teach Anisha B Dua, Adam Kilian, Rebecca Grainger, Sarah A Fantus, Zachary S Wallace, Frank Buttgereit, Beth L Jonas
65 [GO] 2020―Oct―04 Biologics in systemic autoimmune diseases during COVID-19 pandemic Narender Annapureddy, Krishna Nalleballe, Sanjeeva Reddy Onteddu, Rohan Sharma, Sen Sheng, Sukanthi Kovvuru, et al. (+2)
66 [GO] 2020―Sep―29 The impact of COVID-19 pandemic on rheumatology practice: a cross-sectional multinational study Nelly Ziadé, Ihsane Hmamouchi, Lina el Kibbi, Nizar Abdulateef, Hussein Halabi, Fatemah Abutiban, et al. (+4)
67 [GO] 2020―Sep―26 Living with arthritis: a “training camp” for coping with stressful events? A survey on resilience of arthritis patients following the COVID-19 pandemic Jacopo Ciaffi, Veronica Brusi, Lucia Lisi, Luana Mancarella, Martina D’Onghia, Elisabetta Quaranta, et al. (+7)
68 [GO] 2020―Sep―26 COVID-19 reinfection or relapse: an intriguing dilemma Manu Madan, Shekhar Kunal
69 [GO] 2020―Sep―24 Clinical impact of COVID-19 on a French population of spondyloarthritis patients Christian Hubert Roux, O. Brocq, F. Gerald, C. Pradier, L. Bailly
70 [GO] 2020―Sep―17 Moving towards online rheumatology education in the era of COVID-19 Sakir Ahmed, Olena Zimba, Armen Yuri Gasparyan
71 [GO] 2020―Sep―08 Managing rheumatic diseases during COVID-19 Amit P. Ladani, Muruga Loganathan, Abhijeet Danve
72 [GO] 2020―Sep―06 Managing rheumatoid arthritis during COVID-19 Rashmi Roongta, Alakendu Ghosh
73 [GO] 2020―Sep―05 Rheumatologists in the COVID-19 era: will there be a new role for the rheumatologist in the care of rheumatic patients? Jorge Morales-Torres, Francisco Javier Aceves-Ávila
74 [GO] 2020―Sep―03 The potential similarities of COVID-19 and autoimmune disease pathogenesis and therapeutic options: new insights approach Sahar Najafi, Elham Rajaei, Rezvan Moallemian, Forough Nokhostin
75 [GO] 2020―Sep―02 African League Against Rheumatism (AFLAR) preliminary recommendations on the management of rheumatic diseases during the COVID-19 pandemic Richard Oluyinka Akintayo, Rachid Bahiri, Yasser El Miedany, Hakeem Olaosebikan, Asgar Ali Kalla, Adewale Olukayode Adebajo, et al. (+19)
76 [GO] 2020―Aug―27 COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series Clodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, Massimo L’Andolina, Antonio Tavoni, Riccardo Cecchetti, et al. (+22)
77 [GO] 2020―Aug―25 High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review Hiroyuki Fujii, Taisuke Tsuji, Tatsuya Yuba, Shunya Tanaka, Yoshifumi Suga, Aosa Matsuyama, et al. (+6)
78 [GO] 2020―Aug―15 Virtual rheumatology appointments during the COVID-19 pandemic: an international survey of perspectives of patients with rheumatic diseases Alyssa Howren, J. Antonio Aviña-Zubieta, Nevena Rebić, Hallie Dau, Louise Gastonguay, Kam Shojania, et al. (+2)
79 [GO] 2020―Jul―28 Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review Feng He, Qingqing Luo, Ming Lei, Lixin Fan, Xinning Shao, Kaiyuan Hu, et al. (+4)
80 [GO] 2020―Jul―27 Determinants of COVID-19 disease severity in patients with underlying rheumatic disease C. Sieiro Santos, C. Moriano Morales, E. Díez Álvarez, C. Álvarez Castro, A. López Robles, T. Perez Sandoval
81 [GO] 2020―Jul―27 Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology Eduardo Mantovani Cardoso, Jasmin Hundal, Dominique Feterman, John Magaldi
82 [GO] 2020―Jul―25 Challenges in delivering rheumatology care during COVID-19 pandemic A. Nune, K. Iyengar, A. Ahmed, H. Sapkota
83 [GO] 2020―Jul―11 Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad Sakir Ahmed, Olena Zimba, Armen Yuri Gasparyan
84 [GO] 2020―Jun―20 Comment on “Colchicine may not be effective in COVID-19 infection; it may even be harmful?” Senol Kobak
85 [GO] 2020―Jun―20 The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al. Silvia Piantoni, Enrico Colombo, Paolo Airò, Angela Tincani, Antonio Brucato, Franco Franceschini, et al. (+3)
86 [GO] 2020―Jun―19 A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab Shaozhe Cai, Wei Sun, Ming Li, Lingli Dong
87 [GO] 2020―Jun―18 Colchicine as a possible therapeutic option in COVID-19 infection Rafael Parra-Medina, Juan Camilo Sarmiento-Monroy, Adriana Rojas-Villarraga, Edgar Garavito, Giovanni Montealegre-Gómez, Arley Gómez-López
88 [GO] 2020―Jun―17 Impact of anti-rheumatic drugs and steroids on clinical course and prognosis of COVID-19 Carmine Gazzaruso, Nicoletta Carlo Stella, Giuseppe Mariani, Anna Tamburlini, Pietro Garini, Elena Freddi, et al. (+3)
89 [GO] 2020―Jun―17 COVID-19 and Kawasaki disease: an analysis using Google Trends Mrinalini Dey, Sizheng Steven Zhao
90 [GO] 2020―Jun―08 The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress Martina Orlandi, Gemma Lepri, Cosimo Bruni, Yukai Wang, Alessandro Bartoloni, Lorenzo Zammarchi, et al. (+4)
91 [GO] 2020―Jun―04 Antiphospholipid antibodies in patient with acute lower member ischemia and pulmonary thromboembolism as a result of infection by SARS-CoV2 C. Sieiro Santos, C. Nogal Arias, C. Moriano Morales, M. Ballesteros Pomar, E. Diez Alvarez, T. Perez Sandoval
92 [GO] 2020―Jun―03 Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy? Sebastián Ibáñez, Oriela Martínez, Francisca Valenzuela, Francisco Silva, Omar Valenzuela
93 [GO] 2020―May―30 Switching to teleconsultation for rheumatology in the wake of the COVID-19 pandemic: feasibility and patient response in India Padmanabha Shenoy, Sakir Ahmed, Aby Paul, Teny Grace Skaria, Joel Joby, Bazil Alias
94 [GO] 2020―May―30 Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment Mehmet Soy, Gökhan Keser, Pamir Atagündüz, Fehmi Tabak, Işık Atagündüz, Servet Kayhan
95 [GO] 2020―May―30 Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19? Kiana Vakil-Gilani, Kenneth O’Rourke
96 [GO] 2020―May―29 COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments Dieu-Donné Ouédraogo, Wendlassida Joelle Stéphanie Tiendrébéogo, Fulgence Kaboré, Honoré Ntsiba
97 [GO] 2020―May―29 Treatment algorithm for COVID-19: a multidisciplinary point of view Felice Galluccio, Tolga Ergonenc, Alvaro Garcia Martos, Abdallah El-Sayed Allam, Maria Pérez-Herrero, Ricardo Aguilar, et al. (+4)
98 [GO] 2020―May―27 Navigating COVID-19 in the developing world Bridget Hodkinson, Prasun Singh, Ayanda Gcelu, Wilson Bautista Molano, Guillermo Pons-Estel, Deshiré Alpízar-Rodríguez
99 [GO] 2020―May―27 Taking care of systemic sclerosis patients during COVID-19 pandemic: rethink the clinical activity Antonina Minniti, Wanda Maglione, Francesca Pignataro, Carmela Cappadona, Roberto Caporali, Nicoletta Del Papa
100 [GO] 2020―May―27 High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia Carmine Gazzaruso, Nicoletta Carlo Stella, Giuseppe Mariani, Carlo Nai, Adriana Coppola, Daniela Naldani, Pietro Gallotti
101 [GO] 2020―May―26 Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis Adem Kucuk, Medine Cumhur Cure, Erkan Cure
102 [GO] 2020―May―25 Corticosteroid treatment in severe COVID-19 pneumonia: two cases and literature review Jinghong Dai, Yali Xiong, Hui Li, Yajun Qian, Ying Xu, Qingqing Xu, et al. (+2)
103 [GO] 2020―May―23 YouTube as a source of information on COVID-19 and rheumatic disease link Burhan Fatih Kocyigit, Mazlum Serdar Akaltun, Ahmet Riza Sahin
104 [GO] 2020―May―14 COVID-19 with rheumatic diseases: a report of 5 cases Chuanfang Cheng, Chuanjing Li, Tao Zhao, Jing Yue, Fang Yang, Yimin Yan, Xiaoan Liu
105 [GO] 2020―May―11 Colchicine may not be effective in COVID-19 infection; it may even be harmful? Medine Cumhur Cure, Adem Kucuk, Erkan Cure
106 [GO] 2020―May―09 Reply to Rheumatologists’ perspective on coronavirus disease 19: is heparin the dark horse for COVID-19? Sakir Ahmed, Prajna Anirvan
107 [GO] 2020―May―09 How should we overcome the threat by the pandemic of 2019-nCoV? Epidemic simulation using the SIRS model Jun Inamo
108 [GO] 2020―Apr―10 Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets Durga Prasanna Misra, Vikas Agarwal, Armen Yuri Gasparyan, Olena Zimba
 [1] 

108 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.008 sec